NEurocontrolled BIdirectional Artificial Upper Limb and Hand prosthesiS (NEBIAS)

July 28, 2016 updated by: Paolo Maria Rossini
The NEBIAS ("NEurocontrolled BIdirectional Artificial upper limb and hand prosthesiS") proposal aims at developing and clinically evaluating (in selected amputees) a neuro-controlled upper limb prosthesis intuitively controlled and felt by the amputee as the natural one. This will be possible by means of a novel neural interface able to provide a stable and very selective connection with the nervous system. This goal will be achieved by combining microtechnology and material science and will allow, on one side, recording of the motor-related signals governing the actions of the amputated hand/arm for the motion control of a mechanical prosthesis, and on the other providing sensory feedback from tactile and kinesthetic sensors through neuromorphic stimulation of the adequate afferent pathway within the residual limb. The NEBIAS proposal is also aimed at finding out the 'language' intrinsically linking central nervous system with peripheral nerve signals in order to govern simple and complex hand/fingers movements. To reach this goal, a variety of techniques exploring brain and nerve functions will be assembled and integrated; this includes the analysis of electromagnetic brain and nerve signals, as well as of movement-related changes in brain's blood flow/metabolism.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

2

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lazio
      • Roma, Lazio, Italy, 00168
        • Recruiting
        • Fondazione Policlinico Agostino Gemelli
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult man or woman >18 yrs and < 71 yrs.
  • Transradial amputation or Congenital Hand Hypoplasia
  • Amputation in the chronic stable phase
  • Good functionality of muscles of the stump
  • Absence of severe stump pain (VAS<3)

Exclusion Criteria:

  • Cognitive impairment
  • Current or prior psychological impairments: Major personality disturbance (i.e. borderline, antisocial), Major depression, Bipolar I
  • Pregnancy
  • History of or active substance abuse disorder
  • Acquired brain injury with residual impairment
  • Intellectual Disability (IQ < 70)
  • Prior neurological or musculo-skeletal disease
  • Current or prior dermatological conditions
  • Excessive sensitivity to electrical stimulation (people afraid of electrical stimulation or pain)
  • Persons with other diseases that may affect the function of the nervous system. (Diabetes, HIV, Renal Failure)
  • Persons with pacemakers
  • People affected by autoimmune and chronic infective diseases in treatment with immunosuppressive drugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Robotic Hand
The two patient enrolled will perform the task requiring the use of the robotic hand.

The patients will use the robotic hand for a period of one year that will be divided in 3 different phases. The first phase is the intensive phase where the patient will use the robotic hand from Monday to Friday all days. This phase will last 6 weeks. The second phase is the semi-intensive where the patient will use the robotic hand only two days per week. This phase will last 6 weeks. The third phase is the monitoring where the patient will use the robotic hand only one day per week until the end of the trial.

During this phases the patient will perform different task requiring the use of the robotic hand.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
performance of the robotic hand
Time Frame: 1 year
Different level of pressure (percentage of success);
1 year
performance of the robotic hand
Time Frame: 1 year
Virtual egg test (percentage of success);
1 year
performance of the robotic hand
Time Frame: 1 year
Pick and Lift (percentage of success);
1 year
performance of the robotic hand
Time Frame: 1 year
Texture recognition (percentage of success);
1 year
performance of the robotic hand
Time Frame: 1 year
Shape recognition (percentage of success);
1 year
performance of the robotic hand
Time Frame: 1 year
Compliance recognition (percentage of success)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cortical map changes
Time Frame: 1 year
Primary motor area (change of dimension and shape);
1 year
Cortical map changes
Time Frame: 1 year
Primary somatosensory area (change of dimension and shape);
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: paolo m rossini, professor, Catholic University of the Sacred Heart

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2016

Primary Completion (ANTICIPATED)

June 1, 2017

Study Completion (ANTICIPATED)

December 1, 2018

Study Registration Dates

First Submitted

June 23, 2016

First Submitted That Met QC Criteria

July 28, 2016

First Posted (ESTIMATE)

July 29, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

July 29, 2016

Last Update Submitted That Met QC Criteria

July 28, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • FP7- ICT-2013.9.6

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sensorized Hand Prosthesis

Clinical Trials on Robotic Hand

Subscribe